ArticleImmunologic research2025

A nasal vaccine candidate based on S2 and N proteins from SARS-CoV-2 generates a broad antibody response systemically and in the lower respiratory tract.

Yadira Lobaina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.